Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest GSK Stories

GSK Stops Paying Docs To Market Meds
2013-12-18 09:15:55

Rebekah Eliason for redOrbit.com – Your Universe Online Amid accusations of bribery and scandal, GlaxoSmithKline (GSK), one of the leading drug makers, will stop paying doctors to promote its drugs and cease targets for number of prescriptions filled for the marketing staff. This is a first for the giant drug company, which has long been fighting scandals over its sales practices. Such a huge step is a major challenge to other drug companies and could force them to follow their example....

2013-10-23 08:29:42

LONDON, October 23, 2013 /PRNewswire/ -- Global healthcare company GSK reported Q3 results showing group sales growth +1%, earnings per share +16% and strong cash generation which has enabled the company to re-affirm its guidance for the full year. In a video interview, CFO Simon Dingemans said the company was making good progress on reshaping and restructuring its cost base and that GSK was now seeing the benefit of savings in both in its operations and the transformed...

World's First Malaria Vaccine Could Save Millions Of Lives
2013-10-08 11:00:43

Brett Smith for redOrbit.com - Your Universe Online GlaxoSmithKline (GSK) is expected to seek regulatory approval for a malaria vaccine that recently delivered promising results in a large-scale trial conducted across Africa. The new vaccine – dubbed RTS,S – would be the world’s first malaria vaccine and could significantly boost public health in parts of Africa where malaria runs rampant. "In Africa we experience nearly 600,000 deaths annually from malaria, mainly children...

2013-10-02 23:19:21

Reportbuyer.com just published a new market research report: Global Vaccine Market Forecast to 2017. London (PRWEB) October 02, 2013 Of late, the vaccines market is burgeoning with immense activities. Big pharmaceutical companies like GSK, Pfizer, Merck etc. are struggling to maintain their revenue and operating incomes amidst patent cliffs of blockbuster drugs. In such a scenario, vaccines, which have high entry barriers for generic players and the potential to generate blockbuster...

2013-09-17 23:03:16

Reportbuyer.com just published a new market research report: World Pain Relieving Drug Market 2013-2023 London (PRWEB) September 17, 2013 Report Details New study reveals sales potential of this large, expanding market See what the future holds for painkillers. Visiongain's report gives you revenue predictions to 2023. You find data, trends, opportunities and commercial prospects. That new study lets you assess forecasted sales at overall world market, submarket, product and national...

2013-09-09 12:25:16

LONDON, September 9, 2013 /PRNewswire/ -- Record numbers of global pharmaceutical companies and CROs, including Abbvie, GSK, Lilly, Covance, ICON, INC Research, inVentiv Health Clinical, PAREXEL, PPD and PRA International, have entered this year's US Clinical Researcher of the Year, organized by pharmaceutical media company PharmaTimes. "This year's record entry is a result of the outstanding collaborative effort of the leading pharma companies and sponsoring CROs on...

2013-08-27 23:03:04

Leading CPA firm to use Deltek First to standardize on a firm-wide approach to work more efficiently and streamline financial management processes Herndon, VA (PRWEB) August 27, 2013 Deltek, Inc., the leading global provider of enterprise software and information solutions for professional services firms and government contractors, today announced that accounting firm Goldstein Schechter Koch (GSK) has selected Deltek First Maconomy Essentials to work more efficiently as one firm and...

2013-07-23 08:30:12

PITTSBURGH, July 23, 2013 /PRNewswire/ -- Mylan Inc. (NASDAQ: MYL) today announced that the Third Circuit Court of Appeals has reversed a summary judgment ruling dismissing Mylan's claim for breach of contract against GlaxoSmithKline relating to Paroxetine Hydrochloride Extended-release (ER) Tablets. The court ordered that Mylan's contract claim proceed to trial in U.S. District Court for the District of New Jersey. Mylan had filed suit against GSK claiming that GSK's agreement to...

2012-12-14 20:20:56

LONDON, Dec. 14, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate. The effectiveness of raxibacumab is based solely on efficacy...

2012-10-24 11:26:16

RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2012 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) has introduced a new program to help consumers recycle their empty GSK respiratory inhalers and keep waste out of landfills. The "Complete the Cycle(TM) Recycle Program for GSK Respiratory Inhalers is the first of its kind in the pharmaceutical industry and is being offered to community-based retail pharmacies in 31 U.S. markets to make available to their customers. Currently, inhalers may not...